Table 1.

Demographics of patients in the control (placebo) versus study group (gabapentin).

	Gabapentin (n = 17)	Placebo (n = 12)
Mean patient age (yr)	54.6	53.33
Sex (Male/Female)	7/10	6/6
ASA
Class I	1	0
Class II	5	5
Class III	11	7